Skip to content
Tuesday, November 10, 2026
North Network

Zimbabwe Rejects ‘Unbalanced’ American Healthcare Assistance Package Over Information Fears

Medical funding image
The proposed American funding was aimed at initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has turned down a substantial US health deal valued at $367m (£272m) spanning five years due to Washington's request for confidential biological samples.

This move came to light after a official document dated December was disclosed, revealing that President Emmerson Mnangagwa felt the agreement was "lopsided".

A government spokesperson has since explained that the US was requesting genetic material for research and profit but was unwilling to share the benefits from any future medical innovations.

"We will now turn to the challenging and unfortunate process of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.

A medical body in Zimbabwe has appealed for more talks to reach a deal agreeable to all parties so the nation's vital HIV treatment initiative can proceed.

Wider Context

Zimbabwe's decision comes after a similar case in Kenya, where a court suspended a similar health funding agreement following concerns were filed about the security of citizens' health data.

After returning to office last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

The agency had managed aid for the US government, but Trump stated its spending was "inefficient" and his government was pursuing direct bilateral agreements to boost transparency and responsibility.

Based on statements, Sixteen African countries have to date signed these new agreements, constituting more than $18.3bn in new funding.

Specifics of the Rejected Agreement

The funds for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this partnership might have yielded immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving HIV treatment through US-supported programmes," Tremont said.

However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to provide its genetic material and health information for a long time, with no equivalent promise of benefiting from any medical innovations – like new medicines or tests – that might result from that provided information," Mangwana explained.

"In essence, our country would provide the basic resources for scientific discovery with no assurance that the final treatments would be available to our population if a new pandemic emerge."

Sovereignty and Global Health

He also said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were upending structures already established through the global health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with potential pandemics.

"This framework is designed to ensure that when a country contributes its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."

These objections regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We are open to continued dialogue with our American counterparts on how future co-operation could be structured in a way that respects the sovereignty and interests of each country."

Medical Community Reaction

A leading public health body said it understood the official position, but suggested that talks must proceed considering much of the nation's Aids initiatives relied on international support.

"In cases where technical issues arise, such as those involving data governance or implementation frameworks, these can frequently be resolved through detailed discussion and mutually agreed protections," it commented.

This impasse highlights the complex challenges between receiving crucial international aid and protecting a country's data in an increasingly data-driven world.

HH
By

Heather Harvey

A tech strategist with a decade of experience in digital transformation and startup growth.

North Network

Type to search articles.